Skip to content

A new perspective: Development of a cognitive behavioral therapeutic intervention for patients with remaining trauma related symptoms

A new perspective: Development of a cognitive behavioral therapeutic intervention for patients with remaining trauma related symptoms - A cognitive perspective on remaining trauma related symptoms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53700
Enrollment
50
Registered
2022-06-27
Start date
2023-07-25
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-traumatic stress disorder PTSD post-traumatic stress disorder PTSD

Interventions

Based on available literature and multidisciplinary guidelines, an experimental treatment module has been developed. A treatment protocol has been drafted stating the content of all sessions. The trea

Sponsors

Reinier van Arkel
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - All participants are adult (18-64 years) - All adutls are competent - All participants have undergone trauma focused treatment - Despite this treatment, participants continue to experience trauma related  symptoms (PCL score of 33 or more)

Exclusion criteria

Exclusion criteria: - Participants who do not have trauma related symptoms - Participants whose attitude towards the intervention is not in line with the goal of the study (e.g. participant primarily expects symptom reduction instead of improvement in quality of life) - Participants who do not have sufficient mastery of the Dutch language - Participants who show an acute high risk for suicide - Participants who actively and excessively use substances - Participants who show behavioral problems causing interpersonal conflicts and/ or disturbing the group proces - Participants who are suspected to or diagnosed with simulation (as demonstrated by clinical asessment) - Participants whose mental capacity is limited (as demonstrated by clinical asessment) - Participants whom have a psychological/psychotherapeutic treatment during the experimental intervention - Participants of which their medication is altered during the experimental intervention

Design outcomes

Primary

MeasureTime frame
Self-report questionnaires are used to measure quality of life (MANSA-12vn), attribution style (experimental questionnaire), trauma related cognitions (PTCI), and trauma related symptoms (PCL-5).

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Contacts

Public ContactMMPA Muskens

Reinier van Arkel

maarten.muskens@reiniervanarkel.nl0638775544

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)